31 related articles for article (PubMed ID: 25488843)
1. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer.
Niu L; Liu H; Li X; Wang L; Hua H; Cao Q; Xiang Q; Cai T; Zhu D
Bioorg Med Chem; 2024 Jan; 98():117584. PubMed ID: 38168629
[TBL] [Abstract][Full Text] [Related]
3. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
4. Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.
Mock JN; Taliaferro JP; Lu X; Patel SK; Cummings BS; Long TE
Bioorg Med Chem Lett; 2012 Jul; 22(14):4854-8. PubMed ID: 22677312
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.
Akinboye ES; Rosen MD; Denmeade SR; Kwabi-Addo B; Bakare O
J Med Chem; 2012 Sep; 55(17):7450-9. PubMed ID: 22867001
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring.
Andreozzi G; Ambrosio MR; Magli E; Maneli G; Severino B; Corvino A; Sparaco R; Perissutti E; Frecentese F; Santagada V; Leśniak A; Bujalska-Zadrożny M; Caliendo G; Formisano P; Fiorino F
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895954
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists.
Qi Y; Xue B; Chen S; Wang W; Zhou H; Chen H
Front Chem; 2022; 10():1053675. PubMed ID: 36405317
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.
Qi Y; Chen H; Chen S; Shen J; Li J
Front Chem; 2022; 10():947065. PubMed ID: 36046733
[TBL] [Abstract][Full Text] [Related]
9. A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.
Zhang Q; He J; Yu W; Li Y; Liu Z; Zhou B; Liu Y
RSC Med Chem; 2020 Apr; 11(4):427-437. PubMed ID: 33479647
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
[TBL] [Abstract][Full Text] [Related]
11. Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions.
Reilly SW; Mach RH
Org Lett; 2016 Oct; 18(20):5272-5275. PubMed ID: 27736075
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
Chen H; Liang X; Xu F; Xu B; He X; Huang B; Yuan M
Molecules; 2014 Aug; 19(8):12048-64. PubMed ID: 25120056
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety.
Chen H; Xu BB; Sun T; Zhou Z; Ya HY; Yuan M
Molecules; 2017 Oct; 22(11):. PubMed ID: 29109383
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives.
Chen H; Wang CL; Sun T; Zhou Z; Niu JX; Tian XM; Yuan M
Bioorg Med Chem Lett; 2018 May; 28(9):1534-1539. PubMed ID: 29615343
[TBL] [Abstract][Full Text] [Related]
16. A Trojan horse in drug development: targeting of thapsigargins towards prostate cancer cells.
Christensen SB; Skytte DM; Denmeade SR; Dionne C; Møller JV; Nissen P; Isaacs JT
Anticancer Agents Med Chem; 2009 Mar; 9(3):276-94. PubMed ID: 19275521
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Dehydroabietylamine Derived Compounds.
Wiemann J; Al-Harrasi A; Csuk R
Anticancer Agents Med Chem; 2020; 20(15):1756-1767. PubMed ID: 32183684
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
